Figure 4
From: Bioinformatics analysis of prognostic value and immunological role of MeCP2 in pan-cancer
Genetic alterations of MeCP2 in a variety of tumor types. (A) The alteration frequency of MeCP2 in different cancers. (B) The mutation site of the MeCP2 gene. (C,D) The correlation of MeCP2 mutation with MSI sensor score and Mutation count (P < 0.0001). (E,F) The correlation between MeCP2 mutation and Disease Free, Disease Specific (P < 0.05), Overall survival, and Progression Free. (I–J) Radar chart displays the correlation between MeCP2 and both TMB andMSI. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. TMB tumor mutational burden, MSI microsatellite instability.
